Study to Assess Safety,Tolerability,Efficacy of PM01183 and Atezolizumab in Patients w/ Advanced Small Cell Lung Cancer.

NCT04253145 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

184

Enrollment

NETWORK

Sponsor class

Conditions

Carcinoma, Small Cell Lung

Interventions

DRUG: PM 01183
DRUG: Atezolizumab

Sponsor

Fundacion Oncosur